FERNANDO
ALFONSO MANTEROLA
Investigador en el periodo 2008-2013
Hospital do Meixoeiro
Vigo, EspañaPublicaciones en colaboración con investigadores/as de Hospital do Meixoeiro (8)
2012
-
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
The Lancet, Vol. 380, Núm. 9852, pp. 1482-1490
2010
-
Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation
Circulation, Vol. 122, Núm. 10, pp. 1017-1025
-
Thrombosis of second-generation drug-eluting stents in real practice: Results from the multicenter Spanish registry ESTROFA-2 (estudio espaol sobre trombosis de stents farmacoactivos de segunda generacion-2)
JACC: Cardiovascular Interventions, Vol. 3, Núm. 9, pp. 911-919
2008
-
Drug-Eluting Stent Thrombosis. Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)
Journal of the American College of Cardiology, Vol. 51, Núm. 10, pp. 986-990
-
Long-Term Clinical Benefit of Sirolimus-Eluting Stents in Patients With In-Stent Restenosis. Results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) Study
Journal of the American College of Cardiology, Vol. 52, Núm. 20, pp. 1621-1627
2006
-
Eficacia de la implantación del stent recubierto de rapamicina en pacientes diabéticos con vasos muy pequeños (≤2,25 mm). Subanálisis del estudio DIABETES
Revista Espanola de Cardiologia, Vol. 59, Núm. 10, pp. 1000-1007
2003
-
Effects of bosentan on neointimal response following coronary angioplasty
European Journal of Clinical Investigation, Vol. 33, Núm. 9, pp. 762-768
2002
-
Implications of late expansion of self-expanding stents on neointimal response: A serial study with intravascular ultrasound
Revista Espanola de Cardiologia, Vol. 55, Núm. 1, pp. 16-24